Recurrent Melanoma Terminated Phase 2 Trials for 7-Hydroxystaurosporine (DB01933)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00072189A Phase II Study of UCN-01 in Metastatic MelanomaTreatment